US$ 29.10
nad or ghk cu The Best Longevity Peptides for Research in Canada: NAD+, Epithalon, MOTS-c & GHK-Cu GHK-Cu in the NAD+ Push
Description
Fulltext Views 326,693 PDF downloads 55,166

In a phase I trial that ran from 20222023, SNIPR treated 24 healthy patients with three doses of an oral version of their treatment to assess safety

LeRoith D, Yakar S

Created by medical experts

SAVE 15% when you buy our kit

Argente J, Caballo N, Barrios V, Pozo J, Muoz MT, Chowen JA, Hernndez M
